Evidence that combined thromboxane A2 and serotonin receptor blockade might prevent coronary artery thrombosis and the conversion from chronic to acute coronary heart disease syndromes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples